Fresh Recalls

FDAClass II · Drug · Recall D-0725-2026 · Recalled July 29, 2026

Glycopyrrolate Injection recall — Fresenius Kabi USA, LLC

Agency report date: July 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Glycopyrrolate Injection
Company / brand
Fresenius Kabi USA
Lot / serial / date codes
Lot #: 6134349, 6134620 Exp. Date 11/2026
Distribution
Nationwide within in the USA
Agency product description and boundaries

Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of Particulate Matter: Hair was found in product

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Glycopyrrolate Injection

3. Open the official notice or contact

Official recall ID
D-0725-2026
Brand
Fresenius Kabi USA
Classification
Class II
Units affected
59,425 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Lake Zurich, IL, United States
Firm address
3 Corporate Dr, N/A, 60047-8930

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 6134349, 6134620 Exp. Date 11/2026
Distribution
Nationwide within in the USA
Firm notified the public via
Letter
FDA event ID
99449
Recall initiated
July 16, 2026
FDA classified
July 23, 2026
FDA report date
July 29, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page